IMGN

ImmunoGen, Inc. Press Releases

$6.11
*  
4.74
43.69%
Get IMGN Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading IMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    IMGN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial
12/19/2014 1:02:00 AM - Business Wire
▼-43.69 % Price Change since this news event. The Volume Ratio is 16.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ImmunoGen, Inc. Announces Webcast of Presentation at the 33rd Annual J.P. Morgan Healthcare Conference
12/15/2014 12:45:00 PM - Business Wire
▼-35.62 % Price Change since this news event. The Volume Ratio is 0.95.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition
12/6/2014 12:01:00 PM - Business Wire
▼-37.20 % Price Change since this news event. The Volume Ratio is 0.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ImmunoGen, Inc. Announces Clinical and Preclinical Data Presentations at Upcoming 56th ASH Annual Meeting and Exposition
11/24/2014 3:30:00 PM - Business Wire


ImmunoGen, Inc. Announces Clinical and Preclinical Data Presentations at Upcoming 56th ASH Annual Meeting and Exposition
11/24/2014 3:30:00 PM - Business Wire


ImmunoGen, Inc. Again Named One of The Boston Globe’s Top Places to Work
11/13/2014 4:00:00 PM - Business Wire
▼-35.41 % Price Change since this news event. The Volume Ratio is 0.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ventana announces collaboration to develop companion diagnostics for ImmunoGen''s targeted anticancer agents
10/28/2014 11:00:00 AM - PR Newswire


ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results
10/24/2014 6:30:00 AM - Business Wire
▼-33.08 % Price Change since this news event. The Volume Ratio is 0.8.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Ipsen Announces Positive Results from Phase III Clinical Study of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered by Subcutaneous Route to Prostate Cancer Patients
10/10/2014 11:30:00 AM - Business Wire


ImmunoGen, Inc. Announces Conference Call to Discuss Its First Quarter Fiscal Year 2015 Financial Results
10/10/2014 11:30:00 AM - Business Wire
▼-32.86 % Price Change since this news event. The Volume Ratio is 0.93.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day